A. Ferecsko
YOU?
Author Swipe
View article: 020 Galvokimig, a multispecific antibody–based therapeutic, for the treatment of inflammatory skin diseases associated with both type 2 and type 3 inflammation
020 Galvokimig, a multispecific antibody–based therapeutic, for the treatment of inflammatory skin diseases associated with both type 2 and type 3 inflammation Open
View article: The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human <i>in vitro</i> preclinical experiments and clinical samples
The roles of interleukin (IL)-17A and IL-17F in hidradenitis suppurativa pathogenesis: evidence from human <i>in vitro</i> preclinical experiments and clinical samples Open
Background Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease associated with significant comorbidities and poor quality of life. Despite uncertainty about pathways driving inflammation in HS lesions, the cytoki…
View article: 161 IL-17A and IL-17F in the pathogenesis of hidradenitis suppurativa: insights from early and chronic lesions
161 IL-17A and IL-17F in the pathogenesis of hidradenitis suppurativa: insights from early and chronic lesions Open
View article: 509 IL-17A and IL-17F in the pathogenesis of hidradenitis suppurativa: Insights from early and chronic lesions
509 IL-17A and IL-17F in the pathogenesis of hidradenitis suppurativa: Insights from early and chronic lesions Open